Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL3‐mediated m6A mRNA contributes to the resistance of carbon‐ion radiotherapy in non‐small‐cell lung cancer
Xiaofeng Xu, Peiru Zhang, Yangle Huang, et al.
Cancer Science (2022) Vol. 114, Iss. 1, pp. 105-114
Open Access | Times Cited: 24

Showing 24 citing articles:

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 179
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 60
The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Zhonghao Mao, Bingyu Wang, Teng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 23
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Molecular mechanisms of m6A modifications regulating tumor radioresistance
Ruolin Shen, Zhenyang Jiang, Huanhuan Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications
Xiaojuan Su, Yi Feng, Yi Qu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 5, pp. 1121-1136
Open Access | Times Cited: 7
Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization
Xun Chen, Lejia Zhang, Yi He, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization
Xiaodong Ling, Cuicui Qi, Kui Cao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer
Xianxiu Ji, Xiaoying Wan, Hui Sun, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications
Liming Wang, Yuanxin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114846-114846
Open Access | Times Cited: 13
N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications
Dong Wang, Yan Zhang, Qingbo Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115477-115477
Open Access | Times Cited: 11
METTL protein family: focusing on the occurrence, progression and treatment of cancer
Huhu Zhang, Fulin Sun, Shuyao Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis
Wangyang Meng, Xiao Han, Rong Zhao, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
N6‐methyladenosine‐mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1
Xiaobo Shi, Xiaozhi Zhang, X. P. Huang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 3
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
The m6A modification of ACSL4 mRNA sensitized esophageal squamous cell carcinoma to irradiation via accelerating ferroptosis
Yingying Jin, Shupei Pan, Mincong Wang, et al.
Cell Biology International (2024)
Closed Access | Times Cited: 1
m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway
Tinghui Huang, Xudong Ao, Jie Liu, et al.
Translational Oncology (2024) Vol. 51, pp. 102230-102230
Open Access | Times Cited: 1
Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Mohammad B. Uddin, Zhishan Wang, Chengfeng Yang
Advanced Science (2024)
Open Access | Times Cited: 1
The therapeutic potential of RNA m(6)A in lung cancer
Jian Yu, Sun Wei, Xiangxuan Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
Yi Zhang, Wendong Gu, Yingjie Shao
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
METTL3 Drives NSCLC Metastasis by Enhancing CYP19A1 Translation and Oestrogen Synthesis
Wangyang Meng, Xiao Han, Rong Zhao, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy
Liangliang Wang, Rohan R. Katipally, Hua Liang, et al.
Med (2023) Vol. 4, Iss. 12, pp. 863-874
Open Access | Times Cited: 1
Integrated pan-cancer analysis of centromere protein F and experimental verification of its role and clinical significance in cholangiocarcinoma
Zhenyu Cao, Liyun Zeng, Zicheng Wang, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 2
Closed Access
Page 1

Scroll to top